Fatty liver study tracks 922 patients to predict disease course
NCT ID NCT07433205
First seen Mar 22, 2026 · Last updated May 22, 2026 · Updated 6 times
Summary
This study followed 922 adults with or at risk for metabolic fatty liver disease (MASLD) for up to 2 years. Researchers tracked changes in liver stiffness, fat levels, and liver enzymes, as well as serious events like liver failure or heart problems. The goal was to identify which clinical and metabolic factors predict worsening disease and poor outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Sichuan University affiliated Chengdu Second People's Hospital
Chengdu, Sichuan, 610041, China
Conditions
Explore the condition pages connected to this study.